Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis

Fig. 5

Forest plots and meta-analyses of studies showing pooled sensitivity (a) and specificity (b) of CAP for detection of ≥S3 steatosis (Stage 0–2 vs Stage 3) in NAFLD patients. c Summary of AUROC of CAP for the diagnosis of ≥S3 steatosis (Stage 0–2 vs Stage 3) in NAFLD patients

Back to article page